Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
February 20, 2020
NDA

We would like to meet you at the DIA 2020

We would like to meet you at the DIA 2020

-
NDA
-
February 20, 2020

Are you and/or your team attending the DIA next month?  Stop by our booth, D5, and talk to one of our team about how we can support you to optimise your path to approval.

We know that the path to drug approval is littered with pitfalls which can lead to unnecessary delays getting your medicine to the people who need it the most – the patients.

Working together we can:

  • Accelerate your drug development program to reduce your time to approval
  • Optimise the management of the regulatory process to provide accurate and predictable outcomes
  • Reduce your risks and increase the probability of gaining Market Authorization

In addition to our team at the booth we have some great speakers sharing their knowledge in different forums throughout the conference, see below:

Dr Mira Pavlovic – HTA Expert, NDA Regulatory Advisory Board member
Hub 1 #CH104 | Thurs, 7th February – 09:15
Patient-reported, Patient-relevant, Patient-centred outcomes: definitions, roles and importance for health technology assessment

Brian Edwards – Principal Consultant, Pharmacovigilance & Drug Safety
Hub 2 | Tues, 5th February – 13:00
CAST analysis of UK pregnancies reported after isotretinoin administration

Prof. Beatriz Silva Lima – Non Clinical Expert, NDA Regulatory Advisory Board member
Session – #DL04 | Wed, 18th March

Industry – Regulator Dialogue: Tailor-made Regulatory Guidance for Non-clinical to Clinical Development
Panelist: How has the New EU Guideline Changed the Conduct of First in Human Trials in Europe
Speaker: Beatriz Silva Lima

More information

Session – #S0512/0612 | Thu, 19th March
Panoramic Hall – Regulatory Science Training and Network in European Academia
Session Chair: Beatriz Silva Lima

More Information

Click here to download the Preliminary Programme.

Pre-book a meeting with one our team

To book a meeting contact meet-us@ndareg.com we look forward to seeing you at the in Brussels!

The post We would like to meet you at the DIA 2020 appeared first on NDA Group.

Last updated:
February 20, 2020

NDA

NDA is a world leading drug development consultancy with a dedicated team of over 150 consultants supported by an expert network and a specialist Advisory Board. Our goal is to streamline drug development in order to accelerate patient access to important medical therapies.

Click here to read more about us!

Are you and/or your team attending the DIA next month?  Stop by our booth, D5, and talk to one of our team about how we can support you to optimise your path to approval.

We know that the path to drug approval is littered with pitfalls which can lead to unnecessary delays getting your medicine to the people who need it the most – the patients.

Working together we can:

  • Accelerate your drug development program to reduce your time to approval
  • Optimise the management of the regulatory process to provide accurate and predictable outcomes
  • Reduce your risks and increase the probability of gaining Market Authorization

In addition to our team at the booth we have some great speakers sharing their knowledge in different forums throughout the conference, see below:

Dr Mira Pavlovic – HTA Expert, NDA Regulatory Advisory Board member
Hub 1 #CH104 | Thurs, 7th February – 09:15
Patient-reported, Patient-relevant, Patient-centred outcomes: definitions, roles and importance for health technology assessment

Brian Edwards – Principal Consultant, Pharmacovigilance & Drug Safety
Hub 2 | Tues, 5th February – 13:00
CAST analysis of UK pregnancies reported after isotretinoin administration

Prof. Beatriz Silva Lima – Non Clinical Expert, NDA Regulatory Advisory Board member
Session – #DL04 | Wed, 18th March

Industry – Regulator Dialogue: Tailor-made Regulatory Guidance for Non-clinical to Clinical Development
Panelist: How has the New EU Guideline Changed the Conduct of First in Human Trials in Europe
Speaker: Beatriz Silva Lima

More information

Session – #S0512/0612 | Thu, 19th March
Panoramic Hall – Regulatory Science Training and Network in European Academia
Session Chair: Beatriz Silva Lima

More Information

Click here to download the Preliminary Programme.

Pre-book a meeting with one our team

To book a meeting contact meet-us@ndareg.com we look forward to seeing you at the in Brussels!

The post We would like to meet you at the DIA 2020 appeared first on NDA Group.

Last updated:
February 20, 2020

NDA

NDA is a world leading drug development consultancy with a dedicated team of over 150 consultants supported by an expert network and a specialist Advisory Board. Our goal is to streamline drug development in order to accelerate patient access to important medical therapies.

Click here to read more about us!